ESR1 and breast cancer: One study showed that ectopic expression of miR-221 or miR-222 was enough to decrease ERα protein expression in MCF-7 and T47D breast cancer cells, and this led to the cells acquiring resistance to tamoxifen (Figure 4A) [79].